pMSCV-IRES-YFP II (pMIY II) Citations (3)

Originally described in: Generation of T-cell receptor retrogenic mice.
Holst J, Szymczak-Workman AL, Vignali KM, Burton AR, Workman CJ, Vignali DA Nat Protoc. 2006;1(1):406-17. PubMed Journal

---

Articles Citing pMSCV-IRES-YFP II (pMIY II)

Articles
Establishing 177Lu-PSMA-617 radioligand therapy in a syngeneic model of murine prostate cancer. Fendler WP, Stuparu AD, Evans-Axelsson S, Luckerath K, Wei L, Kim W, Poddar S, Said J, Radu CG, Eiber M, Czernin J, Slavik R, Herrmann K. J Nucl Med. 2017 May 25. pii: jnumed.117.193359. doi: 10.2967/jnumed.117.193359. PubMed
Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells. Anantharajan J, Zhou H, Zhang L, Hotz T, Vincent MY, Blevins MA, Jansson AE, Kuan JWL, Ng EY, Yeo YK, Baburajendran N, Lin G, Hung AW, Joy J, Patnaik S, Marugan J, Rudra P, Ghosh D, Hill J, Keller TH, Zhao R, Ford HL, Kang C. Mol Cancer Ther. 2019 Sep;18(9):1484-1496. doi: 10.1158/1535-7163.MCT-18-1239. Epub 2019 Jul 8. PubMed
Identification of new OPA1 cleavage site reveals that short isoforms regulate mitochondrial fusion. Wang R, Mishra P, Garbis SD, Moradian A, Sweredoski MJ, Chan DC. Mol Biol Cell. 2021 Jan 15;32(2):157-168. doi: 10.1091/mbc.E20-09-0605. Epub 2020 Nov 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.